Ruling threatens to upend patents on Moderna’s Covid-19 vaccine
STAT - Analysts said the decision opens the door to a protracted controversy and debate around the implications of the patent
STAT - Analysts said the decision opens the door to a protracted controversy and debate around the implications of the patent
Moderna, racing to develop a vaccine for Covid-19, lost a key patent decision Thursday, one that could delay the company’s progress or force it to hand over a cut of profits. https://t.co/ONosgkUzL0